ICON's Nicole Cowan is interviewed in the latest edition of Clinical OMICs about the new biomarker-driven landscape in clinical trials and the nuances of drug-diagnostics co-development programs. 

Related Information

Webpage

Medical Device and Diagnostics Research Services

Media Article

Biomarkers in Oncology

Case Study

Developoment of Digital Biomarker using Raw Accelerometer Data

Blog

Key Considerations for Disease-Modifying Parkinson’s Disease Trials